title: Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
abstract: BACKGROUND
  Journals have increased disclosure requirements in recent years, in part to deter guest authorship. The prevalence of guest authorship among primary authors (first and last) in the current era of increased disclosure requirements is unknown.
  
  
  OBJECTIVE
  Our aim was to examine the self-reported prevalence of guest authorship among primary authors from a sample of randomized clinical trials with and without industry funding and industry collaboration in the design, analysis or reporting of trials.
  
  
  METHODS
  Cross-sectional analysis of randomized, drug/device clinical trials with published details on the "Role of the Funding Source/Sponsor" published in high-impact biomedical journals between 1 December 2011 and 31 November 2012. Phase 1 or 2 trials, secondary trial analyses, and trials that were not listed on ClinicalTrials.gov were excluded. Primary guest authorship was defined, based on International Committee of Medical Journal Editors (ICMJE) criteria, when neither the first nor last author contributed to either of the following: 1) the design of the trial or the analysis/interpretation of data; or 2) drafting part or all of the manuscript.
  
  
  METHODS
  One hundred and sixty-eight randomized clinical trials that met inclusion criteria were included.
  
  
  METHODS
  We measured differences in the prevalence of guest authorship between trials with neither industry funding nor collaboration and 1) trials with industry funding without collaboration, and 2) trials with industry funding with collaboration.
  
  
  RESULTS
  The overall prevalence of primary guest authorship was 6 % (10/168). Primary guest authorship was significantly more common in trials with industry funding with collaboration than in those with neither industry funding nor collaboration [13.2 % (10/76) vs. 0 % (0/39); p < 0.02]. Primary guest authorship did not differ between trials with industry funding without collaboration and trials with neither industry funding nor collaboration.
  
  
  CONCLUSIONS
  Among a sample of randomized, drug/device clinical trials in high-impact biomedical journals, primary guest authorship was overall uncommon and occurred exclusively among trials with industry funding with collaboration.
authors.affiliation: Weill Cornell Medical College, 535 East 70th Street, 6th Floor, New York, NY, 10021, USA. nitinroper@gmail.com.
authors.forename: Nitin
authors.initials: N
authors.lastname: Roper
authors.affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Deborah
authors.initials: D
authors.lastname: Korenstein
mesh_terms: D001319:Authorship / Q000592:standards*; D016265:Conflict of Interest; D003299:Cooperative Behavior; D003430:Cross-Sectional Studies; D030881:Disclosure / Q000592:standards*; D004345:Drug Industry / Q000191:economics / Q000592:standards*; D035081:Editorial Policies; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000592:standards*
keywords: conflict of interest; guest authorship; honorary authorship; industry collaboration; industry funding; primary guest authorship
references.citation: Lancet. 2009 Mar 21;373(9668):1004; author reply 1004-5
references.pmid: 19304007
references.citation: Zhonghua Gan Zang Bing Za Zhi. 2014 Oct;22(10):781-91
references.pmid: 25558501
references.citation: JAMA Intern Med. 2014 Oct;174(10):1695-6
references.pmid: 25156272
references.citation: BMJ. 2002 Dec 14;325(7377):1391-2
references.pmid: 12480854
references.citation: Circulation. 2009 Sep 8;120(10):906-13
references.pmid: 19738151
references.citation: BMJ. 2011 Oct 25;343:d6128
references.pmid: 22028479
references.citation: PLoS Med. 2010 Aug;8(8):e1001070
references.pmid: 21829331
references.citation: Mayo Clin Proc. 2009 Sep;84(9):811-21
references.pmid: 19720779
references.citation: JAMA. 1994 Feb 9;271(6):438-42
references.pmid: 8295318
references.citation: JAMA. 2008 Apr 16;299(15):1800-12
references.pmid: 18413874
references.citation: BMJ. 2014 Jan 14;348:g171
references.pmid: 24423895
references.citation: JAMA. 2002 Jun 5;287(21):2769-71
references.pmid: 12038907
references.citation: JAMA. 1998 Jul 15;280(3):222-4
references.pmid: 9676661